Results 11 to 20 of about 9,855 (176)
How to cite this article: Hegde A. Candida auris is Coming. Indian J Crit Care Med 2022;26(5):543-544.
openaire +2 more sources
Different efficacies of common disinfection methods against candida auris and other candida species
Background: Candida auris can form long-lasting colonies in the hospital environment and on human skin. There is limited evidence regarding the efficacy of different methods and products for disinfecting hospitals and colonized patients to prevent the ...
Leiwen Fu +7 more
doaj +1 more source
The surge of multidrug-resistant fungal pathogens, especially Candida auris, poses significant threats to global public health. Candida auris exhibits resistance to multiple antifungal drugs, leading to major outbreaks and a high mortality rate.
Ji-Seok Kim +2 more
doaj +1 more source
Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. [PDF]
Candida auris is an emerging yeast pathogen of global significance. Its multidrug-resistant nature and inadequacies of conventional identification systems pose diagnostic and therapeutic challenges. This study investigated occurrence of C.
Ziauddin Khan +5 more
doaj +1 more source
Candida auris is a multidrug-resistant pathogen, that is a well-known cause of nosocomial infections. This pathogen is being identified using advanced diagnostic approaches and epidemiological typing procedures.
Zill-E- Huma +5 more
doaj +1 more source
Candida auris Genetics and Emergence
Candida auris is a multidrug-resistant fungal pathogen that presents a serious threat to global human health. Since the first reported case in 2009 in Japan, C. auris infections have been reported in more than 40 countries, with mortality rates between 30% and 60%. In addition, C.
Anuradha Chowdhary +2 more
openaire +2 more sources
Cell Viability Assays for Candida auris [PDF]
Cell viability assays are useful for assessing the efficacy of antifungal therapeutics and disinfection strategies in vitro. In recent years these assays have been fundamental for the testing of conventional and novel therapies against the nosocomial fungal pathogen Candida auris.
Brown, Jason L. +5 more
openaire +2 more sources
In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care unit (ICU) stays who had recurrent Candida auris (C. auris) in blood despite antifungal therapy. C.
Adnan Alatoom +6 more
doaj +1 more source
Biocide Response of Candida auris. [PDF]
ABSTRACT Candida auris is an emerging multidrug‐resistant yeast demonstrating remarkable persistence in healthcare environments, contributing to nosocomial transmission and outbreak persistence.
Erganis S +3 more
europepmc +3 more sources
Introduction:Candida auris is a major threat to public health. Rapid detection is essential for early treatment and transmission control. The use of chromogenic media allows the presumptive identification of this new species.
Alba Ruiz-Gaitán +8 more
doaj +1 more source

